Insights
Newsletters
2026 Mid-Year Technology and Life Sciences PIPE and RDO Report
Wilson Sonsini is pleased to present the 2026 Mid-Year Technology and Life Sciences PIPE and RDO Report, analyzing 103 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and June 30, 2026.
Newsletters
2026 Mid-Year Technology and Life Sciences IPO Report
Wilson Sonsini's 2026 Mid-Year Technology and Life Sciences IPO Report presents in-depth analysis related to 37 initial public offerings (IPOs) with deal values exceeding $75 million or direct listings completed by U.S.-based technology and life sciences companies between January 1 and June 30, 2026.
Newsletters
European Antitrust Bimonthly Bulletin – July/August 2026
The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which distills the major antitrust developments in Europe over the past two months into concise and actionable takeaways. Companies operating in, or transacting with, Europe should take note of this quarter's developments in merger enforcement, digital markets regulation, and AI-related antitrust scrutiny.
All Results
Alerts
10.02.26
California Passes COMPETE Act Extending State Competition Law to Cover Single-Firm Conduct
On September 30, 2026, Governor Gavin Newsom (D-CA) signed into law AB 1776—the Competition and Opportunity in Markets for a Prosperous, Equitable and Transparent Economy Act (the COMPETE Act). The latest in a series of amendments to the Cartwright Act,1 the COMPETE Act bans monopolization and monopsonization and allows the California attorney general or a California district attorney to bring enforcement actions targeting such conduct.
Client Highlights
10.01.26
Wilson Sonsini Advises Foundational on £8.2 Million Pre-Seed Financing
On October 1, 2026, Foundational, a London-based space technology company, announced it has emerged from stealth with £8.2 million in pre-seed financing to automate and scale Satellite Laser Ranging (SLR), the technique that pins down the position of satellites and debris to millimeter precision. Participants in the round include BACKED, Final Frontier, Adjacent, Type One Ventures, and Inflection. Wilson Sonsini Goodrich & Rosati is advising Foundational on the transaction.
Client Highlights
10.01.26
Wilson Sonsini Advises SpyGlass Pharma on Acquisition of Advanced Vision Science
On October 1, 2026, SpyGlass Pharma, a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions, announced the acquisition of all outstanding shares of Advanced Vision Science (AVS), an ophthalmic medical device company and manufacturer of intraocular lenses (IOLs) and lens materials, for approximately $13 million dollars in cash. This acquisition secures scalable commercial IOL manufacturing capacity for SpyGlass Pharma for its Phase 3 lead product candidate (the BIM-IOL System) and accelerates pathway to adding premium lens options into its IOL-based drug delivery system. Wilson Sonsini Goodrich & Rosati advised SpyGlass Pharma on the transaction.
Client Highlights
10.01.26
Wilson Sonsini Advises Stripe on Acquisition of Parafin
On September 30, 2026, Stripe, the programmable financial services company, announced that it has agreed to acquire Parafin, a leading embedded financial products platform. Wilson Sonsini Goodrich & Rosati is advising Stripe on the transaction.
Client Highlights
9.30.26
Firm Advises Kanu AI on $11.7 Million Seed Funding
On September 30, 2026, Kanu AI, a platform that turns everyday employee tasks into custom software for enterprises, announced $11.7 million in funding led by Trilogy Equity Partners, with participation from a16z speedrun, BMW i Ventures, and Accel. Wilson Sonsini Goodrich & Rosati advised Kanu AI on the transaction.
News Articles
9.30.26
Wilson Sonsini Accepts NLADA 2026 Beacon of Justice Award
On September 24, 2026, Wilson Sonsini Goodrich & Rosati was honored with the 2026 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) at the NLADA Exemplar Awards Gala in Washington, D.C. The awards honor members of the pro bono legal community who are tireless advocates for equal justice. Wilson Sonsini is one of seven law firms nationwide to receive the Beacon of Justice Award for six consecutive years.
Client Highlights
9.30.26
Wilson Sonsini Advises Proximal on $15 Million Seed Round as it Emerges from Stealth
On September 29, 2026, Proximal, a research lab focused on data, launched out of stealth, raising $15 million in seed funding led by General Catalyst. Chemistry, SV Angel, and other investors joined the round. Wilson Sonsini Goodrich & Rosati advised Proximal on the transaction.
Client Highlights
9.30.26
Wilson Sonsini Advises Zenithon AI on $10 Million Seed Financing
On September 30, 2026, Zenithon AI, a London-based AI start-up developing world models for extreme physics applications, including fusion energy, rocketry, and semiconductor manufacturing, announced a $10 million seed financing led by Backed VC, Lunar Ventures, Seraphim Space, MMC Ventures, and SOSV. Several angel investors also participated in the round. Wilson Sonsini Goodrich & Rosati advised Zenithon AI on the transaction.
News Articles
9.30.26
Wilson Sonsini, Jack Davies Shortlisted for 2026 British Legal Awards
On September 30, 2026, Wilson Sonsini Goodrich & Rosati was shortlisted in the “Tech & Telecoms Team of the Year” category for Law.com International’s 2026 British Legal Awards. Wilson Sonsini Of Counsel Jack Davies was also named among the “Rising Stars: Private Practice” finalists. Now in their 17th year, the awards recognize the outstanding contributions of legal professionals, firms, and teams shaping the legal landscape.
Client Highlights
9.29.26
Wilson Sonsini Advises World Labs on $8.2 Billion Acquisition by AMD
On September 28, 2026, AMD, a global semiconductor company, announced it has entered into a definitive agreement to acquire World Labs, an AI model and research lab led by AI pioneer Dr. Fei-Fei Li. The acquisition will bring a world-class team of researchers and model experts to AMD, strengthening its ability to develop AI hardware, software, and systems. Wilson Sonsini Goodrich & Rosati is advising World Labs on the transaction.
Newsletters
9.28.26
2026 Mid-Year Technology and Life Sciences PIPE and RDO Report
Wilson Sonsini is pleased to present the 2026 Mid-Year Technology and Life Sciences PIPE and RDO Report, analyzing 103 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and June 30, 2026.
9.28.26
Wilson Sonsini Advises ADARx on IP Matters Related to IPO and Concurrent Private Placement
On September 24, 2026, ADARx Pharmaceuticals, a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced the pricing of its upsized initial public offering (IPO) of 26,250,000 shares of common stock at $17.00 per share. All of the shares of common stock are being offered by ADARx. The shares began trading on the Nasdaq Global Select Market on September 25, 2026, under the ticker symbol “ADRX.”